<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pagnamenta AT</submitter><funding>National Institute for Health Research (NIHR)</funding><funding>Wellcome Trust</funding><pagination>669-679</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5477361</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(6)</volume><pubmed_abstract>Over 150 different proteins attach to the plasma membrane using glycosylphosphatidylinositol (GPI) anchors. Mutations in 18 genes that encode components of GPI-anchor biogenesis result in a phenotypic spectrum that includes learning disability, epilepsy, microcephaly, congenital malformations and mild dysmorphic features. To determine the incidence of GPI-anchor defects, we analysed the exome data from 4293 parent-child trios recruited to the Deciphering Developmental Disorders (DDD) study. All probands recruited had a neurodevelopmental disorder. We searched for variants in 31 genes linked to GPI-anchor biogenesis and detected rare biallelic variants in PGAP3, PIGN, PIGT (n=2), PIGO and PIGL, providing a likely diagnosis for six families. In five families, the variants were in a compound </pubmed_abstract><journal>European journal of human genetics : EJHG</journal><pubmed_title>Analysis of exome data for 4293 trios suggests GPI-anchor biogenesis defects are a rare cause of developmental disorders.</pubmed_title><pmcid>PMC5477361</pmcid><funding_grant_id>090532/Z/09/Z</funding_grant_id><funding_grant_id>WT098051</funding_grant_id><pubmed_authors>Murakami Y</pubmed_authors><pubmed_authors>Taylor JC</pubmed_authors><pubmed_authors>Mansour S</pubmed_authors><pubmed_authors>Temple IK</pubmed_authors><pubmed_authors>Pagnamenta AT</pubmed_authors><pubmed_authors>DDD Study</pubmed_authors><pubmed_authors>Firth R</pubmed_authors><pubmed_authors>Miller V</pubmed_authors><pubmed_authors>Tadros S</pubmed_authors><pubmed_authors>Popitsch N</pubmed_authors><pubmed_authors>Harrison RE</pubmed_authors><pubmed_authors>Anzilotti C</pubmed_authors><pubmed_authors>Johnson DS</pubmed_authors><pubmed_authors>Taylor JM</pubmed_authors><pubmed_authors>Howard MF</pubmed_authors><pubmed_authors>Kini U</pubmed_authors><pubmed_authors>Rosser E</pubmed_authors><pubmed_authors>Kinoshita T</pubmed_authors><pubmed_authors>Kerr B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Analysis of exome data for 4293 trios suggests GPI-anchor biogenesis defects are a rare cause of developmental disorders.</name><description>Over 150 different proteins attach to the plasma membrane using glycosylphosphatidylinositol (GPI) anchors. Mutations in 18 genes that encode components of GPI-anchor biogenesis result in a phenotypic spectrum that includes learning disability, epilepsy, microcephaly, congenital malformations and mild dysmorphic features. To determine the incidence of GPI-anchor defects, we analysed the exome data from 4293 parent-child trios recruited to the Deciphering Developmental Disorders (DDD) study. All probands recruited had a neurodevelopmental disorder. We searched for variants in 31 genes linked to GPI-anchor biogenesis and detected rare biallelic variants in PGAP3, PIGN, PIGT (n=2), PIGO and PIGL, providing a likely diagnosis for six families. In five families, the variants were in a compound </description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jun</publication><modification>2026-05-04T16:22:23.99Z</modification><creation>2019-03-27T02:48:01Z</creation></dates><accession>S-EPMC5477361</accession><cross_references><pubmed>28327575</pubmed><doi>10.1038/ejhg.2017.32</doi></cross_references></HashMap>